
Article 1 
Decision 2008/911/EC is amended as follows:

1.. Annex I is amended in accordance with Annex I to this Decision;
2.. Annex II is amended in accordance with Annex II to this Decision.
Article 2 
This Decision is addressed to the Member States.
Done at Brussels, 9 December 2009.
For the Commission
Günter VERHEUGEN
Vice-President
ANNEX I

In Annex I to Decision 2008/911/EC, the following two substances are inserted after ‘Calendula officinalis L.’:

— ‘Echinacea purpurea (L.) Moench’
— ‘Eleutherococcus senticosus (Rupr. et Maxim.) Maxim’

ANNEX II

In Annex II to Decision 2008/911/EC, the following is inserted after the entry relating to ‘Calendula officinalis L’:
'
Echinacea purpurea (L.) Moench

Asteraceae

Purple coneflower herb


 BG (bălgarski): пурпурна ехинацея, пресен стрък
 CS (čeština): čerstvá nať třapatky nachové
 DA (dansk): Purpursolhat, frisk urt
 DE (Deutsch): Purpursonnenhutkraut, frisch
 EL (elliniká): Πόα Εχινάκεας της πορφυράς
 EN (English): purple coneflower herb
 ES (español): Equinácea purpúrea, partes aéreas incluidas sumidades floridas
 ET (eesti keel): punane siilkübar
 FI (suomi): kaunopunahattu, tuore verso
 FR (français): parties aériennes fraîches d’échinacée pourpre
 HU (magyar): bíbor kasvirág virágos hajtása
 IT (italiano): Echinacea purpurea, pianta fresca
 LT (lietuvių kalba): rausvažiedžių ežiuolių žolė
 LV (latviešu valoda): purpursarkanās ehinacejas laksti
 MT (malti): Echinacea Vjola
 NL (nederlands): rood zonnehoedkruid
 PL (polski): jeżówka purpurowa, świeże ziele
 PT (português): Equinácea, partes aéreas floridas
 RO (română): iarbã proaspãtã de Echinacea, pãlãria soarelui
 SK (slovenčina): echinacea purpurová, čerstvá vňať
 SL (slovenščina): sveža zel škrlatne ehinaceje
 SV (svenska): röd solhatt, färsk ört
 IS (íslenska): Sólhattur
 NO (norsk): Rød solhatt

Expressed juice and dried expressed juice from fresh flowering aerial parts.

N/A

Traditional herbal medicinal product for treatment of small superficial wounds.

The product is a traditional herbal medicinal product for use in a specified indication exclusively based on long-standing use.

European.

10 to 20 g/100 g of expressed juice or equivalent amount of dried expressed juice in liquid or semi-solid dosage forms.

Adolescents over the age of 12 years, adults, elderly

Small amount of ointment is applied on the affected area 2-3 times a day.

The use in children under 12 years of age is not recommended (see below “Special warnings and precautions for use”).

Cutaneous use.

Do not use the medicinal product for more than 1 week.

If the symptoms persist during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.

Hypersensitivity to the active substance or to plants of the Asteraceae (Compositae) family.

If signs of skin infection are observed, medical advice should be sought.

The use in children below 12 years of age is not recommended because a safe use has not been sufficiently documented.

None reported.

There are no data on cutaneous use during pregnancy or lactation.

Products containing Echinacea should not be applied to the breast of breastfeeding women.

No studies on the effects on the ability to drive and use machines have been performed.

Hypersensitive reactions (local rash, contact dermatitis, eczema and angioedema of the lips) may occur.

The frequency is not known.

If other adverse reactions not mentioned above occur, a doctor or a qualified healthcare practitioner should be consulted.

No case of overdose has been reported.

Eleutherococcus senticosus (Rupr. et Maxim.) Maxim.

Araliaceae

Eleutherococcus root


 BG (bălgarski): елеутерокок, корен
 CS (čeština): eleuterokokový kořen
 DA (dansk): Russisk rod
 DE (Deutsch): Taigawurzel
 EL (elliniká): Pίζα Eλευθεροκόκκου
 EN (English): Eleutherococcus root
 ES (español): Eleuterococo, raíz de
 ET (eesti keel): eleuterokokijuur
 FI (suomi): venäjänjuuren juuri
 FR (français): racine d’éleuthérocoque (racine de ginseng sibérien)
 HU (magyar): Szibériai ginszeng gyökér (tajga gyökér)
 IT (italiano): Eleuterococco radice
 LT (lietuvių kalba): Eleuterokokų šaknys
 LV (latviešu valoda): Eleiterokoka sakne
 MT (malti): Għerq ta’ l-elewterokokku
 NL (nederlands): Russische ginsengwortel
 PL (polski): korzeń eleuterokoka
 PT (português): Raiz de Ginseng Siberiano
 RO (română): Rădăcină de ginseng siberian
 SK (slovenčina): Všehojovcový koreň
 SL (slovenščina): korenina elevterokoka
 SV (svenska): Rysk rot
 IS (íslenska): Síberíu ginseng, rót
 NO (norsk): Russisk rot

Comminuted herbal substance for preparation of a herbal tea

Liquid extract (1:1, ethanol 30-40 % v/v)

Dry extract (13-25: 1, ethanol 28-40 % v/v)

Dry extract (17-30: 1, ethanol 70 % v/v)

Dry aqueous extract (15-17:1)

Tincture (1:5, ethanol 40 % v/v)

Eleutherococcus — Eleutherococci radix (ref.: 01/2008: 1419 corrected 6.0)

Traditional herbal medicinal product for symptoms of asthenia such as fatigue and weakness.

The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.

Chinese, European.

Not applicable.

Adolescents over 12 years of age, adults, elderly

Herbal preparations.

Daily dose.

Comminuted herbal substance as herbal tea: 0,5-4 g.

Tea preparation: 0,5 to 4 g of comminuted herbal substance for infusion in 150 ml of boiling water.

Dosage frequency: 150 ml of tea infusion should be divided in one to three doses taken during the day.

Liquid extract: 2-3 ml.

Dry extracts (ethanol 28-70 % v/v) corresponding to 0,5-4 g dried root.

Dry aqueous extract (15-17:1): 90-180 mg.

Tincture: 10-15 ml.

The daily dose can be taken in one to three doses.

The use is not recommended in children under 12 years of age (see below “Special warnings and precautions for use”).

Oral use.

Not to be taken for more than 2 months.

If the symptoms persist for more than 2 weeks during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.

Hypersensitivity to the active substance.

Arterial hypertension.

The use in children under 12 years of age is not recommended because sufficient experience is not available.

If the symptoms worsen during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.

None reported.

Safety during pregnancy and lactation has not been established.

In the absence of sufficient data, the use during pregnancy and lactation is not recommended.

No studies on the effect on the ability to drive and use machines have been performed.

Insomnia, irritability, tachycardia and headaches may occur. The frequency is not known.

No case of overdose has been reported.
'
